Hexo (TSX:HEXO) Stock Soars 9% as Revenue Nearly Doubled in Q2

Hexo (TSX:HEXO)(NYSE:HEXO) stock soared by 9% shortly after the opening bell, as investors cheered a strong rise in revenue in the second quarter.

| More on:

Hexo (TSX:HEXO)(NYSE:HEXO) released its second-quarter financial results on Thursday morning. Hexo stock soared by 9% shortly after the opening bell, as investors cheered a strong rise in revenue.

The pot company strengthened its positions in several key Canadian markets outside Quebec while maintaining its leading competitive position in Quebec.

Hexo posted a loss of $20.8 million in the second quarter

Hexo is a consumer packaged goods cannabis company, which creates and distributes products to serve the global cannabis market. It serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis, and Original Stash brands, and it serves the medical market under HEXO medical cannabis.

Hexo posted a loss of $20.8 million in its most recent quarter, as revenue nearly doubled from a year earlier.

The cannabis company said its loss stood at $0.17 per diluted share for the quarter ended January 31.

The result compares to a loss of $298.2 million, or $4.52 per diluted share a year earlier, when the company incurred significant one-time charges related to its goodwill and intangible assets.

Hexo’s total net revenue were $32.8 million, up 94% from the same quarter a year earlier and 12% up from the first quarter of fiscal 2021 ended October 31, 2021. The company achieved positive adjusted EBITDA. This quarter marks Hexo’s seventh consecutive quarter of adjusted EBITDA improvement.

Non-beverage Canadian adult-use revenue increased by 72% from the second quarter of 2020.

Adult-use net revenue rose 10.5% in the second quarter, marking the fifth consecutive quarter of growth.

Hexo remains number one in Quebec

Hexo has kept its number one position for market share in Quebec while increasing adult-use net revenue in the rest of Canada to 49% of the company’s sales mix, up from 44% in the first quarter of 2021.

Sebastien St-Louis, Hexo CEO and co-founder, said in a statement: “Our continued focus on delighting consumers has seen us increase our market share across Canada while maintaining the number one position in Quebec. We’re also very excited to have launched ‘powered by HEXO’ CBD beverages in Colorado. Our net revenues and gross margin have continued to improve year over year, bolstered by our premium product mix with the relaunch of UP Cannabis.”

UP Cannabis brand gross revenues increased to $3.2 million, representing 8% of total adult-use, non-beverage gross revenue in the second quarter of 2021 compared to less than 1% in the first quarter due to the successful relaunch of the UP brand at the end of first quarter.

Brand mix, including the UP Cannabis brand, increased non-beverage adult-use gross margin  to 37%, up from 36% in the first quarter.

Hexo has maintained the number one position in the beverages category with net revenues up 11% from the first quarter.

Last month, Hexo announced a deal to buy competitor Zenabis Global in a $235 million deal that will give the cannabis company a European footprint and strengthen its domestic business.

Sébastien St-Louis said the deal with Zenabis will help accelerate national and international growth. The acquisition would place Hexo firmly in the top three positions among licensed producers for sales of adult cannabis in Canada, according to the most recent interim quarterly financial statements.

Hexo stock is overvalued

While Hexo’s growth is impressive, it’s preferable to wait before buying shares, because Hexo stock is overvalued, with a P/S of 12.34.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Stephanie Bedard-Chateauneuf has no position in any of the stocks mentioned. The Motley Fool recommends HEXO.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »